The veterinary oncology specialists included Sue Ettinger, DVM, DACVIM (Oncology), Take C.H.A.R.G.E. scientific advisory board member, as well as a dvm360® editorial advisory board member; and Theresa (Terry) W. Fossum, DVM, MS, PhD, Diplomate ACVS, Take C.H.A.R.G.E. scientific advisory board co-chair. Both experts provided insight and advice surrounding veterinary oncology. Additionally, the Gallup survey and its implications were presented to help the audience better understand dog cancer and thus, help protect them from the disease.
“The Gallup was a survey of just under 6000 people and 67% of them were pet owners. A couple of interesting things really stood out,” Ettinger said, in a dvm360® interview.
“The prevalence of cancer was about 3.4% which is a little bit lower than we see in people. But what really stood out to me and what was interesting and scary was the incidence, so newly diagnosed cancer in dogs, and that was 2.8% and that was 5 times what we’re seeing in human cancer. So that is why this registry is so important so we can really break down the cancer in dogs and understand it at a state level, by breed, by cancer, by age, and gender as well,” she added.
Ettinger emphasized the importance of early cancer detection while highlighting proactive methods for pet owners during her presentation at the Take C.H.A.R.G.E event. “I strongly encourage everyone once a month—so I think about when you’re doing heartworm preventative, flea, and tick preventative—to do a nose-to-tail lump and bump exam. If the mass is the size of a pea, which is the size of a M&M or a skittle and been there a month, you want to go to your veterinarian for a simple test called an aspirate,” she said.
Co-sponsored by TogoRun—a health care communications company—and Intelligent Veterinary Enhanced Experience (Ivee)—a software company that helps organize and standardize healthcare data—the Take C.H.A.R.G.E. initiative included words from Glo Janata, JD, TogoRun president, CEO, and owner, and Chelsea Rhoads, Ivee CEO and founder. Their companies united as key players in helping to launch this significant registry and event.
“I think [Take C.H.A.R.G.E.] will impact the animal health industry in a huge [number] of ways,” said Rhoads, in a dvm360® interview. “Understanding what’s going on in the trends between breeds and gender and location is a game changer. There are so many ways this can grow and create a huge impact for veterinary medicine.”
“[Canine cancer is] a topic that’s close to so many people’s hearts . . . so I think [my favorite part of the Take C.H.A.R.G.E. event was] just being able to see everyone out here at the park on such a wonderful day to celebrate National Cancer Canine Awareness Day for the first time and to learn about the registry,” added Janata, during the interview.
In addition to canine cancer insights, Broadway stars performed consisting of talented and lively actors, singers, playwrights, and beyond. Their powerful voices traveled through the city park as they sang popular songs—and even some music spotlighting the one-of-a-kind love dogs offer us.
“I want to acknowledge how the Broadway community has dealt with data and reality to take charge of their art and bring Broadway back to all of us. We are so lucky to be able to hear the singers today,” Conte expressed.
Last, there was a video presentation featuring all the Broadway performers accompanied by their dogs covering Frank Sinatra’s “It Had to Be You” for a heartwarming conclusion.
To help advance canine oncology research and support the initiative, dog owners and veterinary professionals can submit dog cancer records to the Take C.H.A.R.G.E. website.
Reference
Gallup survey of dog owners. Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Accessed May 24, 2022. https://takechargeregistry.com/about
